{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:09Z","timestamp":1790118849285,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Nature Science Foundation of Jiangsu Province","award":["BK20130705"],"award-info":[{"award-number":["BK20130705"]}]},{"name":"Research of Guangdong Province and Ministry of Education","award":["2014B090901046"],"award-info":[{"award-number":["2014B090901046"]}]},{"DOI":"10.13039\/501100010042","name":"Special Fund for Agro-scientific Research in the Public Interest","doi-asserted-by":"crossref","award":["201103032"],"award-info":[{"award-number":["201103032"]}],"id":[{"id":"10.13039\/501100010042","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T04:15:49Z","timestamp":1469074549000},"page":"4392-4398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus"],"prefix":"10.1016","volume":"34","author":[{"given":"Jun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.vaccine.2016.07.020_b0005","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1128\/JVI.03186-12","article-title":"Cellular chaperonin CCT gamma contributes to rabies virus replication during infection","volume":"87","author":"Zhang","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.07.020_b0010","unstructured":"Who expert consultation on rabies \u2013 introduction. WHO technical report series; 2005. p. 1\u201388."},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.020_b0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/153685902317401726","article-title":"Rabies vaccines: from the past to the 21(st) century","volume":"21","author":"Kammer","year":"2002","journal-title":"Hybrid Hybrid"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.020_b0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/JVI.01572-14","article-title":"Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of Type I interferon","volume":"89","author":"Barkhouse","year":"2015","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2016.07.020_b0025","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1128\/JVI.00326-10","article-title":"Expression of MIP-1 alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.020_b0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"Faul","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.07.020_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.virol.2014.09.010","article-title":"Recombinant rabies virus expressing IFN alpha 1 enhanced immune responses resulting in its attenuation and stronger immunogenicity","volume":"468","author":"Wang","year":"2014","journal-title":"Virology"},{"issue":"36","key":"10.1016\/j.vaccine.2016.07.020_b0040","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/j.vaccine.2014.06.058","article-title":"A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice","volume":"32","author":"Koraka","year":"2014","journal-title":"Vaccine"},{"issue":"35SI","key":"10.1016\/j.vaccine.2016.07.020_b0045","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.vaccine.2015.03.088","article-title":"Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate","volume":"33","author":"Fontana","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.020_b0050","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.vaccine.2015.12.041","article-title":"Inactivation of rabies virus by hydrogen peroxide","volume":"34","author":"Abd-Elghaffar","year":"2016","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2016.07.020_b0055","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.07.020_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vetmic.2014.03.037","article-title":"Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model","volume":"171","author":"Wu","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.07.020_b0065","article-title":"A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.020_b0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11262-016-1313-2","article-title":"A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro","volume":"52","author":"Luo","year":"2016","journal-title":"Virus Genes"},{"issue":"18","key":"10.1016\/j.vaccine.2016.07.020_b0075","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.07.020_b0080","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-387040-7.00009-3","article-title":"Rabies virus as a research tool and viral vaccine vector","author":"Gomme","year":"2011"},{"issue":"e254149","key":"10.1016\/j.vaccine.2016.07.020_b0085","article-title":"Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2016.07.020_b0090","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Wen","year":"2011","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2016.07.020_b0095","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"P Natl Acad Sci USA"},{"issue":"42","key":"10.1016\/j.vaccine.2016.07.020_b0100","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.vaccine.2014.07.102","article-title":"Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c","volume":"32","author":"Wilson","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2016.07.020_b0105","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1128\/jvi.65.12.6544-6552.1991","article-title":"Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus","volume":"65","author":"Parrish","year":"1991","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2016.07.020_b0110","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00705-006-0753-8","article-title":"Analysis of VP2 gene sequences of canine parvovirus isolates in India","volume":"151","author":"Chinchkar","year":"2006","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.07.020_b0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0065-3527(08)60317-6","article-title":"The autonomously replicating parvoviruses of vertebrates","volume":"33","author":"Cotmore","year":"1987","journal-title":"Adv Virus Res"},{"issue":"8","key":"10.1016\/j.vaccine.2016.07.020_b0120","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1128\/jvi.70.8.5422-5429.1996","article-title":"Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles","volume":"70","author":"Hurtado","year":"1996","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.07.020_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.vetmic.2011.06.022","article-title":"Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae","volume":"154","author":"Feng","year":"2011","journal-title":"Vet Microbiol"},{"issue":"4729","key":"10.1016\/j.vaccine.2016.07.020_b0130","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.4059921","article-title":"Natural variation of canine parvovirus","volume":"230","author":"Parrish","year":"1985","journal-title":"Science (New York, N.Y.)"},{"issue":"272","key":"10.1016\/j.vaccine.2016.07.020_b0135","article-title":"Genotyping and pathobiologic characterization of canine parvovirus circulating in Nanjing, China","volume":"10","author":"Zhao","year":"2013","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2016.07.020_b0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/viro.1996.0021","article-title":"Evolution of canine parvovirus involved loss and gain of feline host range","volume":"215","author":"Truyen","year":"1996","journal-title":"Virology"},{"issue":"05","key":"10.1016\/j.vaccine.2016.07.020_b0145","first-page":"41","article-title":"Method of RT-PCR for detection of rabies virus","volume":"2015-10-18","author":"Zhou","year":"2015","journal-title":"Guangdong J Animal Vet Sci"},{"issue":"UNSP e633846","key":"10.1016\/j.vaccine.2016.07.020_b0150","article-title":"Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.020_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1135(86)90035-0","article-title":"An improved hemagglutination test for study of canine parvovirus","volume":"12","author":"Senda","year":"1986","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.07.020_b0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2460\/javma.1982.180.01.37","article-title":"Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination","volume":"180","author":"Pollock","year":"1982","journal-title":"Javma-J Am Vet Med A"},{"issue":"5","key":"10.1016\/j.vaccine.2016.07.020_b0165","first-page":"778","article-title":"Cloning of canine parvovirus VP2 gene and its use as DNA vaccine in dogs","volume":"88","author":"Gupta","year":"2005","journal-title":"Curr Sci India"},{"issue":"6","key":"10.1016\/j.vaccine.2016.07.020_b0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0264-410X(97)00239-9","article-title":"Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus","volume":"16","author":"Jiang","year":"1998","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2016.07.020_b0175","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1016\/j.vaccine.2007.02.051","article-title":"Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2","volume":"25","author":"Patial","year":"2007","journal-title":"Vaccine"},{"issue":"PII S0264-410X0200200-121-22","key":"10.1016\/j.vaccine.2016.07.020_b0180","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/S0264-410X(02)00200-1","article-title":"Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses","volume":"20","author":"Nicholas","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.07.020_b0185","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1128\/jvi.69.11.7274-7277.1995","article-title":"Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence","volume":"69","author":"Casal","year":"1995","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.07.020_b0190","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/jvi.68.7.4506-4513.1994","article-title":"First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs","volume":"68","author":"Langeveld","year":"1994","journal-title":"J Virol"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2016.07.020_b0195","article-title":"Oral immunization of wildlife against rabies: concept and first field experiments","volume":"10","author":"Wandeler","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2016.07.020_b0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630603X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630603X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:18:41Z","timestamp":1749007121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630603X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":40,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X1630603X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}